Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation

被引:15
作者
Renard, Dimitri [1 ]
Collombier, Laurent [2 ]
Demattei, Christophe [3 ]
Wacongne, Anne [1 ]
Charif, Mahmoud [4 ]
Ayrignac, Xavier [4 ]
Azakri, Souhayla [4 ]
Gaillard, Nicolas [5 ]
Boudousq, Vincent [2 ]
Lehmann, Sylvain [6 ]
de Champfleur, Nicolas Menjot [7 ]
Thouvenot, Eric [1 ,8 ]
机构
[1] CHU Nimes, Hop Caremeau, Dept Neurol, 4 Rue Pr Debre, F-30029 Nimes 4, France
[2] CHU Nimes, Hop Caremeau, Dept Nucl Med, Nimes, France
[3] CHU Nimes, Hop Caremeau, Dept Biostat BESPIM, Nimes, France
[4] CHU Montpellier, Hop Gui Chauliac, Dept Neurol, Montpellier, France
[5] CH Perpignan, Dept Neurol, Perpignan, France
[6] Univ Montpellier, CHU Montpellier, Lab Biochim Proteomique Clin, Hop St Eloi,IRMB,CRB,Inserm,U11183, Montpellier, France
[7] CHU Nimes, Hop Caremeau, Dept Med Imaging, Nimes, France
[8] Univ Montpellier, UMR5203, Inst Genom Fonct, Montpellier, France
关键词
Amyloid; florbetaben; imaging; BETA-RELATED ANGIITIS; POSITRON-EMISSION-TOMOGRAPHY; CENTRAL-NERVOUS-SYSTEM; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; SUPERFICIAL SIDEROSIS; COGNITIVE IMPAIRMENT; CSF BIOMARKER; QUANTIFICATION; MICROBLEEDS;
D O I
10.3233/JAD-170843
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Cerebral amyloid angiopathy-related inflammation (CAA-ri) is associated with a cerebrospinal fluid (CSF) biomarker profile similar to that observed in CAA. Few CAA-ri patients have been studied by fibrillar amyloid-beta (A beta) imaging (using C-11-Pittsburgh compound B and F-18-florbetapir, but not F-18-florbetaben). Objective: To describe CSF biomarkers, magnetic resonance imaging (MRI), and F-18-florbetaben (FBB)-positron emission tomography (PET) changes in CAA-ri patients. Methods: CSF levels of total tau, phosphorylated tau, A beta(1-42), and A beta(1-40), MRI (cerebral microbleeds count on susceptibility-weighted imaging and semi-quantitative analysis of fluid-attenuation inversion recovery white matter hyperintensities), and FBB-PET (using both cerebellar cortex and pons to calculate standardized uptake value ratios) were analyzed in nine consecutive CAA-ri patients. Results: A median number of 769 cerebral microbleeds/patient were counted on MRI. When using the pons as reference region, amyloid load on FBB-PET was very strongly correlated to CSF A beta(1-40) levels (rho = -0.83, p = 0.008) and moderately correlated to cerebral microbleed numbers in the occipital lobes (rho = 0.59, p = 0.001), while comparisons with other CSF biomarkers were not statistically significant (total tau, rho = -0.63, p = 0.076; phosphorylated tau, rho = -0.68, p = 0.05; A beta(1-42), rho = -0.59, p = 0.09). All correlations were weaker, and not statistically significant, when using the cerebellum as reference region. A non-significant correlation (rho = -0.50, p = 0.18) was observed between CSF A beta(1-40) levels and cerebral microbleed numbers. Conclusion: In CAA-ri, CSF A beta(1-40) levels correlated well with amyloid load assessed by FBB-PET when the pons was used as reference, and to a lesser degree with cerebral microbleeds count on MRI. This confirms earlier data on CSF A beta(1-40) as an in vivo marker for CAA and CAA-ri.
引用
收藏
页码:1107 / 1117
页数:11
相关论文
共 50 条
  • [41] Cerebral amyloid angiopathy-related inflammation: clinical features and treatment response in a case series
    Martin-Jimenez, P.
    Sanchez-Tornero, M.
    Llamas-Velasco, S.
    Guerrero-Molina, M. P.
    Gonzalez-Sanchez, M.
    Martin, A. Herrero-San
    Blanco-Palmero, V
    Calleja-Castano, P.
    Francisco-Gonzalo, J.
    Hilario, A.
    Ramos, A.
    Salvador, E.
    Toldos, O.
    Hernandez-Lain, A.
    Perez-Martinez, D. A.
    Villarejo-Galende, A.
    NEUROLOGIA, 2023, 38 (08): : 550 - 559
  • [42] Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS A Comparative Study
    Grangeon, Lou
    Boulouis, Gregoire
    Capron, Jean
    Bala, Fouzi
    Renard, Dimitri
    Raposo, Nicolas
    Ozkul-Wermester, Ozlem
    Triquenot-Bagan, Aude
    Ayrignac, Xavier
    Wallon, David
    Gerardin, Emmanuel
    Kerschen, Philippe
    Sablot, Denis
    Formaglio, Maite
    Pico, Fernando
    Turc, Guillaume
    Verny, Marc
    Humbertjean, Lisa
    Gaudron, Marie
    Vannier, Stephane
    Dequatre, Nelly
    Guillon, Benoit
    Isabel, Clothilde
    Arquizan, Caroline
    Detante, Olivier
    Godard, Sophie
    Casolla, Barbara
    Levraut, Michael
    Gollion, Cedric
    Gerfaud-Valentin, Mathieu
    Kremer, Laurent
    Daelman, Laure
    Lambert, Nicolas
    Lanthier, Sylvain
    Poppe, Alexandre
    Regent, Alexis
    Weisenburger-Lile, David
    Verdure, Pierre
    Quesney, Gerald
    Vautier, Mathieu
    Wacongne, Anne
    Thouvenot, Eric
    Pariente, Jeremie
    Coulette, Sarah
    Labauge, Pierre M.
    Olivier, Nadege
    Allou, Thibaut
    Zephir, Helene
    Neel, Antoine
    Bresch, Saskia
    NEUROLOGY, 2024, 103 (02)
  • [43] Cerebrospinal Fluid Amyloid β40 Is Decreased in Cerebral Amyloid Angiopathy
    Verbeek, Marcel M.
    Kremer, Berry P. H.
    Rikkert, Marcel Olde
    van Domburg, Peter H. M. F.
    Skehan, Maureen E.
    Greenberg, Steven M.
    ANNALS OF NEUROLOGY, 2009, 66 (02) : 245 - 249
  • [44] Cerebrospinal Fluid Beta-Amyloid Concentration and Clinical and Radiographic Manifestations of Cerebral Amyloid Angiopathy
    Alten, Baris
    Gokcal, Elif
    Warren, Andrew
    van Veluw, Susanne J.
    Kozberg, Mariel
    Gurol, M. Edip
    Viswanathan, Anand
    Greenberg, Steven M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (05):
  • [46] Cerebral Amyloid Angiopathy-Related Transient Focal Neurologic Episodes
    Smith, Eric E.
    Charidimou, Andreas
    Ayata, Cenk
    Werring, David J.
    Greenberg, Steven M.
    NEUROLOGY, 2021, 97 (05) : 231 - 238
  • [47] Cerebral amyloid angiopathy related inflammation: three case reports and a review
    Chung, Kong Khi
    Anderson, Neil E.
    Hutchinson, David
    Synek, Beth
    Barber, P. Alan
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (01) : 20 - 26
  • [48] Cerebral Amyloid Angiopathy in Patients with Cognitive Impairment: Cerebrospinal Fluid Biomarkers
    Rothenberg, Kasia Gustaw
    Bekris, Lynn
    Leverenz, James B.
    Wu, Jenny
    Lee, Jonathan
    Statsevych, Volodymyr
    Ruggieri, Paul
    Jones, Stephen E.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2024, 53 (05) : 248 - 254
  • [49] Imaging Findings of Cerebral Amyloid Angiopathy, Ab-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation A Single-Institution 25-Year Experience
    Salvarani, Carlo
    Morris, Jonathan M.
    Giannini, Caterina
    Brown, Robert D., Jr.
    Christianson, Teresa
    Hunder, Gene G.
    MEDICINE, 2016, 95 (20)
  • [50] Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis
    Charidimou, Andreas
    Friedrich, Jan O.
    Greenberg, Steven M.
    Viswanathan, Anand
    NEUROLOGY, 2018, 90 (09) : E754 - +